Modular Medical Net Income
| MODD Stock | USD 0.22 -0.003 -1.36% |
Momentum
Sell Extended
Oversold | Overbought |
As of the 13th of March 2026, the last recorded price for Modular Medical is 0.22 per share. Primary technical drivers reflect Standard Deviation of 9.68, mean deviation of 5.52, and Risk Adjusted Performance of -0.04. Quantitative analysis incorporates volatility metrics and price behavior to assess directional bias. Below $1.00, price stability and volume dispersion are closely evaluated. Metrics are compared to industry averages to assess relative positioning.
Recent filings indicate that Total Revenue continues flat. The preceding year’s Total Revenue stood at 0.00. As of 03/13/2026, Gross Profit is forecasted to advance to approximately -1.2 M this yearModular Medical's financials reveal the company's operational efficiency, debt management, and growth trajectory across multiple reporting periods. Core indicators shaping Modular Medical's market valuation are listed below:There are currently one hundred twenty fundamental measures for Modular Medical that can be evaluated and compared over time across peers. Active traders should verify all of Modular Medical's latest fundamental drivers against the trend between 2010 and 2026 to make sure the company can sustain itself in the future. As of 03/13/2026, Market Cap is forecasted to advance to approximately 14.9 M this year. Also, Enterprise Value is forecasted to advance to approximately 12.8 M this year. Equity Screeners provides expanded screening access beyond individual equity pages.| Last Reported | Projected for Next Year | ||
| Net Loss | -16.9 M | -16.1 M | |
| Net Loss | -16.9 M | -16.1 M | |
| Net Loss | -12.5 M | -11.9 M | |
| Net Loss | -0.58 | -0.61 | |
| Net Income Per E B T | 1.15 | 1.10 |
Modular | Net Income | Build AI portfolio with Modular Stock |
Analyzing Modular Medical's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Modular Medical's current valuation and future prospects.
Latest Modular Medical's Net Income Growth Pattern
Below is the plot of the Net Income of Modular Medical over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Modular Medical financial statement analysis. It represents the amount of money remaining after all of Modular Medical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Modular Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Modular Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported -18.82 M | 10 Years Trend |
|
Net Income |
| Timeline |
Modular Net Income Regression Statistics
| Arithmetic Mean | -6,908,614 | |
| Coefficient Of Variation | -115.75 | |
| Mean Deviation | 7,159,941 | |
| Median | -2,539,498 | |
| Standard Deviation | 7,996,991 | |
| Sample Variance | 64T | |
| Range | 18.8M | |
| R-Value | -0.89 | |
| Mean Square Error | 13.6T | |
| R-Squared | 0.80 | |
| Slope | -1,416,652 | |
| Total Sum of Squares | 1023.2T |
Modular Net Income History
Other Fundumenentals of Modular Medical
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Modular Medical Net Income component correlations
Modular Net Income Driver Correlations
Projecting a fair value for Modular Stock accurately depends on understanding the correlations between Modular Medical's key financial drivers, including Net Income. Since Modular Medical's financial accounts are interconnected across its income statement, balance sheet, and cash flow statement, changes in one account typically affect the others.
Click cells to compare fundamentals
The market value of Modular Medical is measured differently than book value, which reflects Modular accounting equity. Modular Medical's market capitalization is 31.32 M. With a P/B ratio of 5.24, the market values Modular Medical well above its book equity. Enterprise value stands at 28.37 M. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
Note that Modular Medical's intrinsic value and market price are different measures derived from different inputs. For Modular Medical, key inputs include a P/B ratio of 5.24, and ROE of -3.32%. Trading price represents the transaction level agreed by market participants.
What if' Analysis
Running a what-if backtest on Modular Medical gives investors a practical way to test how changes in horizon, position size, or market timing might have affected the result. Used properly, this review helps investors decide whether Modular Medical's historical reward profile was stable enough to support the current thesis.
| 12/13/2025 |
| 03/13/2026 |
If you invested 0.00 in Modular Medical on December 13, 2025 and closed the position today, you would earn 0.00 in aggregate gains. The change equals a 0.0% return on investment in Modular Medical on balance over a 90 day window. Modular Medical is related to or competes with Vicarious Surgical, Nexalin Technology, IBio Common, Hyperion DeFi, Iterum Therapeutics, Myomo, and AN2 Therapeutics. Peer context can support comparative analysis. Modular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercializa... More
Modular Medical Upside and Downside Indicators Signals
Upside and downside indicators for Modular Medical summarize momentum balance and potential range context for the stock. The signals are presented as informational context for recent price movement.
| Information Ratio | -0.05 | |||
| Maximum Drawdown | 65.66 | |||
| Value At Risk | -8.11 | |||
| Potential Upside | 11.76 |
Modular Medical Market Risk Indicators Signals
Market risk indicators summarize volatility and return dispersion for Modular Medical. This view provides neutral context for risk and variability.| Risk Adjusted Performance | -0.04 | |||
| Jensen Alpha | -0.51 | |||
| Total Risk Alpha | 0.0287 | |||
| Treynor Ratio | -0.59 |
The concept of mean reversion suggests that Modular Medical's price will eventually return toward its long-run average. High prices may deter value investors, while unusually low prices often attract buyers who anticipate a recovery.
Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | -0.04 | |||
| Market Risk Adjusted Performance | -0.58 | |||
| Mean Deviation | 5.52 | |||
| Coefficient Of Variation | -1,786 | |||
| Standard Deviation | 9.68 | |||
| Variance | 93.72 | |||
| Information Ratio | -0.05 | |||
| Jensen Alpha | -0.51 | |||
| Total Risk Alpha | 0.0287 | |||
| Treynor Ratio | -0.59 | |||
| Maximum Drawdown | 65.66 | |||
| Value At Risk | -8.11 | |||
| Potential Upside | 11.76 | |||
| Skewness | -2.40 | |||
| Kurtosis | 9.4 |
Modular Medical Backtested Returns
Over the selected 3 months, Modular Medical demonstrates an extremely high risk exposure. It shows an Efficiency (Sharpe) Ratio of -0.0409, quantifying negative return efficiency across 3 months. Signal processing identified twenty-one dispersion-based indicators. Please analyze metrics such as risk-adjusted performance of -0.04, standard deviation of 9.68, and mean deviation of 5.52 to assess dispersion and downside exposure. The company owns a Beta (Systematic Risk) of 0.93, which conveys possible diversification benefits within a given portfolio. With a beta near 1, Modular Medical is expected to mirror market movements with minimal deviation in either direction. At this point, Modular Medical has a negative expected return of -0.37%. Please make sure to confirm Modular Medical's the relationship between the total risk alpha and day median price, to decide if Modular Medical's performance from the past will be repeated in the future.
Auto-correlation | -0.45 |
Modest reverse predictability
Serial correlation analysis for Modular Medical reveals modest reverse predictability across the intervals from 13th of December 2025 to 27th of January 2026 and from 27th of January 2026 to 13th of March 2026. The degree of alignment between past and current intervals shapes expectations about Modular Medical's price persistence. At -0.45, just about 45.0% of current Modular Medical price movement aligns with historical price trajectory. Given that Modular Medical has negative autocorrelation for the selected time horizon, market participants may evaluate potential contrarian price behavior over comparable future intervals.
| Correlation Coefficient | -0.45 | |
| Spearman Rank Test | -0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Modular Medical reported net income of -18.82 Million. This is 105.52% lower than that of the Health Care Equipment & Supplies sector and 107.91% lower than that of the Health Care industry. The net income for all United States stocks is 103.3% higher than that of the company.
Modular Net Income Peer Comparison
Comparing Modular Medical to its peers on Net Income is a standard technique for assessing relative investment value. Investors use this approach to identify whether Modular Medical's Net Income is better or worse than comparable stocks and to uncover undervalued alternatives.Modular Medical is currently under evaluation for net income relative to top peers.
Modular Medical Current Valuation Drivers
Key valuation metrics for Modular Medical are extracted from the analysis of Modular Medical's financial statements across multiple reporting periods. These indicators assess how efficiently Modular Medical's generates profit relative to its revenue, operational costs, and shareholder equity.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 22.1M | 23.0M | 30.0M | 15.8M | 14.2M | 14.9M | |
| Enterprise Value | 19.2M | 24.4M | 21.1M | 13.5M | 12.2M | 12.8M |
Modular Medical Institutional Holders
The institutional holdings of Modular Medical reflect the portion of Modular Medical's outstanding shares owned by large professional investors such as pension funds, mutual funds, and financial institutions.| Shares | Perritt Capital Management Inc. | 2025-09-30 | 85 K | Blair William & Co | 2025-09-30 | 67.6 K | Northern Trust Corp | 2025-09-30 | 61.9 K | Navigation Wealth Management, Inc. | 2025-12-31 | 55.1 K | Morgan Stanley - Brokerage Accounts | 2025-09-30 | 53 K | Bank Of America Corp | 2025-09-30 | 45.9 K | Warberg Asset Management Llc | 2025-09-30 | 45 K | Chicago Partners Investment Group Llc | 2025-09-30 | 40.4 K | Jane Street Group Llc | 2025-09-30 | 30 K | Solas Capital Management Llc | 2025-12-31 | 4.4 M | Bard Associates Inc | 2025-09-30 | 3.1 M |
Modular Fundamentals
| Return On Equity | -3.32 | ||||
| Return On Asset | -1.5 | ||||
| Current Valuation | 28.37 M | ||||
| Shares Outstanding | 139.81 M | ||||
| Shares Owned By Insiders | 2.95 % | ||||
| Shares Owned By Institutions | 16.45 % | ||||
| Number Of Shares Shorted | 312.37 K | ||||
| Price To Book | 5.24 X | ||||
| EBITDA | -17.39 M | ||||
| Net Income | -18.82 M | ||||
| Cash And Equivalents | 13.7 M | ||||
| Cash Per Share | 1.25 X | ||||
| Total Debt | 816 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 14.09 X | ||||
| Book Value Per Share | 0.08 X | ||||
| Cash Flow From Operations | -15.72 M | ||||
| Short Ratio | 0.98 X | ||||
| Earnings Per Share | -0.49 X | ||||
| Target Price | 8.0 | ||||
| Number Of Employees | 53 | ||||
| Beta | -0.14 | ||||
| Market Capitalization | 31.32 M | ||||
| Total Asset | 18.73 M | ||||
| Retained Earnings | -84.75 M | ||||
| Working Capital | 12.25 M | ||||
| Net Asset | 18.73 M |
Financial Metrics, Fundamentals & Methodology
Modular Medical reports ROE of -3.32%, debt-to-equity of 0.01. The financial architecture of Modular Medical reflects how effectively it converts operations into retained value. Cash-flow generation trends help validate reported earnings quality. Latest reported fundamentals for Modular Medical include EPS loss of 0.49, current ratio of 14.09, debt-to-equity of 0.01.
For Modular Medical, this section uses periodic company reporting and market reference feeds with Macroaxis normalization rules applied to keep cross-asset comparisons consistent. Intraday timing differences may exist. Statement-level metrics reflect company-reported GAAP or IFRS formats for the relevant filing period.
This content is curated and reviewed by:
Gabriel Shpitalnik - Member of Macroaxis Editorial BoardAlso Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.More Resources for Modular Stock Analysis
A structured review of Modular Medical often starts with core financial statements and trend context. Financial ratios provide context for profitability, efficiency, and growth trends. Below are reports that help frame Modular Medical Stock in context:The market value of Modular Medical is measured differently than book value, which reflects Modular accounting equity. Modular Medical's market capitalization is 31.32 M. With a P/B ratio of 5.24, the market values Modular Medical well above its book equity. Enterprise value stands at 28.37 M. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
Note that Modular Medical's intrinsic value and market price are different measures derived from different inputs. For Modular Medical, key inputs include a P/B ratio of 5.24, and ROE of -3.32%. Trading price represents the transaction level agreed by market participants.